Xtan 37.5 mg Injection 5 ml belongs to a class of medications called ‘tocolytic agents. It is used in adult women from week 24 to week 33 of the pregnancy to delay the premature birth of the baby. Premature labour occurs when the cervix opens after week 20 but before week 37 of pregnancy as a consequence of regular contractions. Preterm labour can result in premature delivery.
Xtan 37.5 mg Injection 5 ml contains Atosiban, which works by weakening the contractions of the uterus. It also reduces the frequency with which contractions occur. It accomplishes this by inhibiting the function of oxytocin, a natural hormone in your body that causes uterine contractions.
A qualified healthcare professional will administer Xtan 37.5 mg Injection 5 ml. The common side effects are injection site reactions, feeling sick (nausea), being sick (vomiting), headache, feeling dizzy, hot flushes, fast heartbeat, low blood pressure, feeling dizzy or light-headed, and high blood sugar. These side effects usually go away without requiring any treatment. However, if these side effects persist or worsen, inform your doctor immediately.
Xtan 37.5 mg Injection 5 ml may not be suitable for everyone, so tell your doctor about any medical conditions you have, especially if you are less than 24 weeks pregnant, more than 33 weeks pregnant, or amniotic fluid loss (premature rupture of your membranes), or if you have completed 30 weeks of your pregnancy or more, if your unborn baby (foetus) has an abnormal heart rate, or if you have bleeding from your vagina. You should stop breastfeeding while you are given Xtan 37.5 mg Injection 5 ml.